ReviewBioImpacts : BI2025
Revolutionizing cancer therapy: Monoclonal antibodies in radiosensitization.
Abolfazl Bemidinezhad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewBioImpacts : BI2025
Abolfazl Bemidinezhad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.